Amgen (AMGN): No Change to Outlook Following AdCom Vote - Baird
Tweet Send to a Friend
Baird analyst, Brian Skorney, noted that the AdCom panel voted unanimously (26-0) in favor of approval of Amgen's ABP 501 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
